Kesimpta Meets Safety, Efficacy and Flexibility Needs of Relapsing MS, Experts Say
Kesimpta (ofatumumab) is a safe and effective treatment for relapsing multiple sclerosis (MS), with an ease of delivery that makes it more convenient than comparable therapies, experts say. Developed and marketed by Novartis, Kesimpta was recently approved by the…